Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.
Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Kempen JH, et al. Among authors: rosenbaum jt. Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55. doi: 10.1080/09286580701585892. Ophthalmic Epidemiol. 2008. PMID: 18300089
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer KJ. Kempen JH, et al. Among authors: rosenbaum jt. Am J Ophthalmol. 2008 Dec;146(6):802-12.e1. doi: 10.1016/j.ajo.2008.04.035. Epub 2008 Jun 25. Am J Ophthalmol. 2008. PMID: 18579112 Free PMC article.
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.
Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Kaçmaz RO, et al. Among authors: rosenbaum jt. Am J Ophthalmol. 2008 Dec;146(6):828-36. doi: 10.1016/j.ajo.2008.06.019. Epub 2008 Aug 16. Am J Ophthalmol. 2008. PMID: 18708181 Free PMC article.
Azathioprine for ocular inflammatory diseases.
Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Pasadhika S, et al. Among authors: rosenbaum jt. Am J Ophthalmol. 2009 Oct;148(4):500-509.e2. doi: 10.1016/j.ajo.2009.05.008. Epub 2009 Jul 1. Am J Ophthalmol. 2009. PMID: 19570522 Free PMC article.
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE. Kempen JH, et al. Among authors: rosenbaum jt. BMJ. 2009 Jul 3;339:b2480. doi: 10.1136/bmj.b2480. BMJ. 2009. PMID: 19578087 Free PMC article.
Epidemiology and course of disease in childhood uveitis.
Smith JA, Mackensen F, Sen HN, Leigh JF, Watkins AS, Pyatetsky D, Tessler HH, Nussenblatt RB, Rosenbaum JT, Reed GF, Vitale S, Smith JR, Goldstein DA. Smith JA, et al. Among authors: rosenbaum jt. Ophthalmology. 2009 Aug;116(8):1544-51, 1551.e1. doi: 10.1016/j.ophtha.2009.05.002. Ophthalmology. 2009. PMID: 19651312 Free PMC article.
Methotrexate for ocular inflammatory diseases.
Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Gangaputra S, et al. Among authors: rosenbaum jt. Ophthalmology. 2009 Nov;116(11):2188-98.e1. doi: 10.1016/j.ophtha.2009.04.020. Epub 2009 Sep 12. Ophthalmology. 2009. PMID: 19748676 Free PMC article.
515 results